Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GSK

Eamonn Holmes on his experience with shingles saying 'It scared the life out of me'

"When you look at the factors for both of us, we had both gone through stressful experiences, your bereavement, me a court case..."

Belfast Live

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

The Conversation

Revealed: how many days FTSE 100 companies have staff in the office

Hybrid and flexible working is offered at most FTSE 100 companies, survey results suggest

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Office days: The full list of average weekly working patterns at FTSE 100 companies

Here is the full list of respondents and their feedback to a Evening Standard survey looking at weekly working patterns, writes Joanna Hodgson

Evening Standard

A technicality could withhold RSV shots

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

Salon

Workers resume strike action as union admit dispute could drag on

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Daily Record

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

The Guardian - UK

Prime-Time Battles Drive GSK And Novo Nordisk In 2023; Novartis Preps Its Spinoff

GSK stock and NVO stock rose Wednesday, though both beat forecasts. Novartis stock skidded on lighter-than-expected sales.

Investors Business Daily

FTSE 100 Live: Vodafone revenues fall in Europe, GSK profits rise

Interest rates are today expected to rise another 0.5% to 4% as the Bank of England continues the fight against inflation with its 10th increase in a row.

Evening Standard

BMW Makes Morningstar List of Undervalued Foreign Stocks

Foreign equity markets have lagged the U.S. in recent years, making the valuations of overseas stocks attractive.

The Street

Moderna Scores A Win In RSV — But Its Shares Don't Reflect That

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Investors Business Daily

Relief for millions of UTI sufferers with new medicine breakthrough

Experts are calling gepotidacin a massive step forwards in the fight against resistance to antibiotics

The Independent UK

Kilwinning roadworks alert as 'frustrating' disruption set to last for one month

Roads to be dug up as a result of cabling work.

Daily Record

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Pharmaceutical Stocks Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market

Big Pharma stalwarts are on the brink of launching the first-ever RSV vaccines, potentially enriching the pharmaceutical stocks.

Investors Business Daily

Moderna Comes Swinging For Pfizer, GSK In The Mega-Billions RSV Market

Moderna stock surged early Wednesday after the company said its experimental RSV vaccine proved nearly 84% effective.

StockNews.com

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Daily Record

GSK facing months of industrial action as workers go on strike at pharma giant

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

GSK to move back to central London with new HQ

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

The Guardian - UK

Moonpig flotation price, like so many, was always pie-in-the-sky thinking

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

The Guardian - UK

GSK shares surge as US judge dismisses Zantac cancer claims

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

The Street

Morningstar Lists Undervalued Stocks with Strong Profits

As of Nov. 11, just 29% of Morningstar-covered stocks that reported Q3 earnings beat estimates by at least 10%.

AFP

EU watchdog backs Sanofi Covid booster jab

The Hague (AFP) - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

Investors Business Daily

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review

The stock market rally tumbled after Fed chief Powell signaled a higher peak rate. The jobs report and heavy earnings also swung stocks.

1 … 6 7 8 9

People

Margherita Della Valle

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.